Table 4.
Pooled analysis of all measures over time from COVID+ ICU patients according to outcome
| ICU positive outcome | ICU negative outcome | p | |
|---|---|---|---|
| Patients (n) | 15 | 8 | |
| Leukocytes a | 14 466 | 12 293 | <0.01 |
| Lymphocytes a | 1183 | 993 | <0.01 |
| Lymphocytes (%) | 26.7 | 7.7 | 0.15 |
| B lymphocytes (%) | 14.4 | 16 | 0.74 |
| B lymphocytes a | 164 | 135 | <0.01 |
| T lymphocytes (%) | 72.8 | 70.5 | 0.625 |
| T lymphocytes a | 887 | 631 | <0.01 |
| Activated T lymphocytes (%) | 18.7 | 17.7 | 0.589 |
| CD4+ lymphocytes (%) | 49.6 | 51.3 | 0.340 |
| CD4+ lymphocytes a | 572 | 442 | <0.01 |
| CD8+ lymphocytes (%) | 21.4 | 17.5 | 0.01 |
| CD8+ lymphocytes a | 294 | 172 | <0.01 |
| NK cells (%) | 11.9 | 12.1 | 0.427 |
| NK‐cells a | 141 | 105 | <0.01 |
| T4/T8‐Ratio | 3.0 | 3.9 | 0.046 |
| Monocytes a | 668 | 637 | 0.694 |
| Monocytes (%) | 5.1 | 5.5 | 0.962 |
| HLA‐DR+CD14+ Monocytes (%) | 31.1 | 21.6 | 0.036 |
| Classical monocytes (%) | 83 | 80.8 | 0.310 |
| Intermediate monocytes (%) | 7.4 | 7.2 | 0.793 |
| Nonclassical monocytes (%) | 2.4 | 1.7 | 0.242 |
| C Reactive Protein (g/dL) | 125.6 | 197.6 | <0.01 |
| Thrombocytes a | 2 62 900 | 1 78 400 | <0.01 |
| Hamoglobin (g/dL) | 8.6 | 8.5 | 0.89 |
| Interleukin 6 (pg/mL) | 624 | 1560 | <0.01 |
| Ferritin (μg/L) | 1253 | 2295 | <0.01 |
| B/T8 | 0.93 | 1.16 | 0.045 |
a
Values shown are mean cells/μL.
Bold values represent statistic significant comparisons.
p values are not adjusted for multiple comparisons.
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.